Healthcare: Cann(‘t)Trust? And, What’s Behind Gilead’s Latest Mega-Deal

Industry Focus - A podcast by The Motley Fool

Categories:

Business

Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.